Quotient Diagnostics Ltd - Medical Equipment - Deals and Alliances Profile - new report released
 |
| companiesandmarkets.com |
2009-11-10 15:37:05 -
Quotient Diagnostics Ltd - Medical Equipment - Deals and Alliances Profile - a new market research report on companiesandmarkets.com www.companiesandmarkets.com/Summary-Company-Profile/quotient-dia ..
Quotient Diagnostics Ltd - Medical Equipment - Deals and Alliances Profile
Summary
Quotient Diagnostics Ltd, a privately-held medical device company is engaged in the discovery, development and marketing of products for the treatment of diabetes and associated diseases. The companys analytical system for A1c, Quo-Test will deliver accurate and precise results. It is used to measure the percentage of haemoglobin molecules that
are glycated and is clinically to assess the risk of long term complications in diabetes. The company is headquartered in Surrey, United Kingdom
The Quotient Diagnostics Ltd - Medical Equipment - Deals and Alliances Profile is an essential source for company data and information. The profile examines the companys key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy as well as highlighting the companys major recent financial deals.
Scope
- Provides key company information for business intelligence needs
- Gives information on the companys major recent financial deals including Mergers and Acquisitions, asset transactions, PE/VC deals, equity offerings, debt offerings and partnerships.
- Data is supplemented with details on the companys history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.
Reasons to buy
- A quick ""one-stop-shop"" to understand the company.
- Support sales activities by understanding your customers businesses.
- Qualify prospective partners and suppliers.
- Understand and respond to your competitors business structure, strategy and prospects through.
- Understanding the key deals which have shaped the company.